Randomized Trial of Pegmolesatide for the Treatment of Anemia in Patients With Nondialysis CKD

Randomized Trial of Pegmolesatide for the Treatment of Anemia in Patients With Nondialysis CKD

Introduction: Pegmolesatide has been recently approved for treating anemia in chronic kidney disease (CKD) patients in China. We presented the results of the pivotal study conducted in patients with nondialysis-dependent (NDD)-CKD with anemia. Methods: This randomized, active-controlled, open-label,...

Full description

Saved in:
Bibliographic Details
Main Authors: Jianteng Xie, Aicheng Yang, Hongyu Qiu, Xiaomei Peng, Wanhong Lu, Xiangyang Huang, Qinkai Chen, Aimin Zhong, Shuifu Tang, Qin Wang, Chuan Li, Liangliang He, Xiaohong Jia, Anran Ma, Fan Wang, Xueqing Yu
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Kidney International Reports
Subjects:
anemia
chronic kidney disease
epoetin alfa
nondialysis
pegmolesatide
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024924034016
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items